The latest announcement is out from Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ).
Shanghai Junshi Biosciences Co., Ltd. has announced a board meeting scheduled for March 27, 2025, to consider and approve the company’s final results for the year ending December 31, 2024. The meeting will also discuss the recommendation of a final dividend and other business matters, potentially impacting the company’s financial strategy and shareholder returns.
More about Shanghai Junshi Biosciences Co., Ltd. Class H
Shanghai Junshi Biosciences Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biosciences industry. The company focuses on the development and commercialization of innovative therapies for various diseases.
YTD Price Performance: 20.03%
Average Trading Volume: 1,428,211
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$26.93B
For an in-depth examination of 1877 stock, go to TipRanks’ Stock Analysis page.